Department of Medicine

(courtesy of the CDC)
April 4, 2024

Tick bites and alpha-gal syndrome focus of $3.5M research grant

Vanderbilt’s Scott Smith, MD, PhD, has been awarded a five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to study the human immune response to tick bites and its role in preventing tick-borne illnesses.

By Paul Govern
(iStock image)
April 3, 2024

Talbot leads US immunization committee

Infectious diseases researcher H. Keipp Talbot, MD, MPH, has been appointed chair of the Advisory Committee on Immunization Practices of the U.S. Centers for Disease Control and Prevention.

By Paul Govern
(iStock image)
April 3, 2024

Excess salt linked to heart disease deaths in low-income group: study

Excessive consumption of dietary sodium likely was responsible for up to 30% of cardiovascular disease-related deaths among mostly low-income participants in a large cohort study conducted by Vanderbilt University Medical Center.

By Bill Snyder
From left, Jennifer Pietenpol, PhD, Eric Farber-Eger, Lauren LeStourgeon, MPH, Luisella Spiga, PhD, and John Kuriyan, PhD.
April 2, 2024

VUMC research staff honored for excellence in the lab, clinic

Laboratory and administrative personnel at Vanderbilt University Medical Center were honored on March 29 for research excellence during the 20th annual Research Staff Awards Ceremony.

By Bill Snyder
Ashton Bertel, left, and Lexi Browning were among the patients who came to the pediatric transplant transition day. (photo by Susan Urmy)
April 1, 2024

Event introduces pediatric transplant patients to their new adult transplant team providers

VUMC’s adult and pediatric heart transplant programs recently collaborated to create a pediatric transplant transition day, a new event where pediatric transplant patients meet with their new adult transplant team providers to begin the transition to those providers.

By Matt Batcheldor
(iStock image)
April 1, 2024

Cell-specific variations in gene regulation may be key to treating pulmonary fibrosis

An international research team co-led by Vanderbilt University Medical Center has revealed how variations in gene regulation in different cell types drive pulmonary fibrosis, a progressive respiratory disorder characterized by scarring and loss of functional lung tissue.

By Bill Snyder
March 29, 2024

Anna Hemnes named director of the Division of Allergy, Pulmonary and Critical Care Medicine

Anna Hemnes, MD, has been named director of the Division of Allergy, Pulmonary and Critical Care Medicine, physician-in-chief of the Vanderbilt Lung Institute and director of the Center for Lung Research.
By Nancy Humphrey
March 29, 2024

A gunshot to the head. A long recovery. Then a wedding.

Special Agent Adam Daniels celebrates ongoing recovery after gunshot causes traumatic brain injury; family’s gift will support care of others with similar injuries
By Jill Clendening
March 29, 2024

VUMC’s John Koethe named director of the Tennessee Center for AIDS Research

John Koethe, MD, MSCI, associate professor of Medicine in the Division of Infectious Diseases at Vanderbilt University Medical Center, has been appointed director and principal investigator of the Tennessee Center for AIDS Research.
By Bill Snyder
March 28, 2024

Teams to create one-stop resource for human pancreatic data to foster diabetes research

Leading investigators in diabetes, pancreas and islet biology, and computational biology have received $12.5 million in two five-year awards from the National Institutes of Health (NIH) to create the world’s first, integrated knowledge base of human-derived tissue- and cellular-level pancreatic information to support innovative, collaborative and reproducible research.
By Jill Clendening
March 28, 2024

Study identifies molecule as potential target for treating AML

While immune checkpoint inhibitors that target the PD-1 molecule on T-cells have proven to be effective with many cancers, these immunotherapies have not worked for acute myeloid leukemia (AML), but new research has identified a “cousin” molecule as a potential therapeutic target for AML. 
By Tom Wilemon
March 27, 2024

Higher genetic risk of obesity means working out harder for same results 

Study authors used activity, clinical and genetic data from the National Institutes of Health’s All of Us Research Program to explore the association of genetic risk of higher body mass index and the level of physical activity needed to reduce incident obesity. 
By Craig Boerner
March 26, 2024

GRADE Study expands results of major NIH-sponsored comparative study of glucose lowering medications in Type 2 diabetes

The study, which included more than 5,000 volunteers with Type 2 diabetes from diverse racial and ethnic groups, compared the treatments insulin glargine, liraglutide, glimepiride and sitagliptin.
1 … 7 8 9 10 11 … 116